Cell Cycle Regulation of NF- B-Binding Activity in Cells
from Human Glioblastomas
Sameer A. Ansari,
1
Mahmut Safak,
1
Luis Del Valle, Sahnila Enam, Shohreh Amini, and Kamel Khalili
2
Center for Neurovirology and Cancer Biology, College of Science and Technology, Temple University,
1900 North 12th Street, 015-96, Philadelphia, Pennsylvania 19122
Glioblastoma multiforme is a highly malignant and
anaplastic tumor of the central nervous system repre-
senting more than 50% of all malignant gliomas. The
cell origin of this highly undifferentiated tumor re-
mains obscure, although it is postulated that glioblas-
tomas are developed from astrocytes. The rapid
growth of the glioma and the state of its undifferen-
tiation are attributed to the deregulation of several
signal transduction pathways and cell cycle events.
Recent studies showed diverse functions for the NF-
B/Rel family of inducible transcription factors in-
cluding differentiation, apoptosis, oncogenesis, and
cell cycle regulation. We sought to examine the level of
NF-B activity throughout the glioma’s cell cycle. Re-
sults from band-shift studies indicated a biphasic
NF-B DNA-binding activity in the nuclei of cycling
glioblastoma cells. We showed that NF-B-binding ac-
tivity maximizes in nuclear extracts at specific cell
cycle stages including G0/G1, mid-late G1, and S phase.
Results from Northern blotting studies revealed that
the differential expression of the NF-B subunits, p50
and p65, may not be responsible for cell cycle stage-
specific association of NF-B subunits with DNA. How-
ever, results from Western blotting analysis utilizing
nuclear extracts from glioma cells throughout the cell
cycle demonstrated that the nuclear accumulation of
p50 and p65 perfectly correlates with their DNA-bind-
ing activity. These observations suggest that the nu-
clear translocation of the p50/p65 subunit of NF-B in
glioma cells is cell cycle stage-dependent and that is
distinct from the differential mRNA expression of
these genes during glioma cell cycling. The possible
role of NF-B in glioma cell formation and regulation
of cellular genes by NF-B in these tumor cells is dis-
cussed. © 2001 Academic Press
INTRODUCTION
The NF-B/Rel family of transcription factors is a
critical component of signal transduction pathways
that regulate genes involved in inflammatory and im-
mune responses. Recent evidence implicates NF-B/
Rel proteins in diverse functions mediating antiapop-
totic pathways, differentiation, and cell cycle
regulation. Interestingly, the small multigene NF-B/
Rel family shares homology with the v-rel oncogene
from the avian transforming retrovirus, reticuloendo-
theliosis virus strain T, suggesting that NF-B/Rel
members may function in growth control or oncogene-
sis via mitogenic pathways [1].
Prototypical NF-B, the best-characterized complex
of the NF-B family, consists of the p50 and p65 het-
erodimer and is regulated by inhibitor proteins (IBs)
[2–5]. A family of IB proteins, which are present in
the cytoplasm, bind to NF-B heterodimers consisting
of p50 and p65 subunits in a ternary complex and mask
their nuclear localization signals [6]. Upon induction
by a stimulus, IBs are phosphorylated for proteolysis
[7, 8] by the ubiquitin-26S proteasome pathway [9] or
by a proteolytic-independent mechanism [10], leading
to nuclear translocation of the p50/p65 heterodimer
complex. In nuclei, NF-B heterodimers bind to well-
defined DNA sequences, 5'-GGGACTTTCC-3', found
within the enhancers of many regulatory and structur-
ally important cellular genes to stimulate their levels
of transcription. NF-B-binding activity has been
shown to be regulated by several environmental factors
such as exposure to cytokines, UV, and viral infection.
In addition, NF-B-binding activity can be modulated
during the cell cycle and previous studies have shown
induction of NF-B at the G0/G1 transition in fibro-
blasts in response to serum [11]. Rel-related proteins
localize the nucleus at specific phases of the cell cycle
[12, 13] and RelA may act as an effector for the
p21BCR-ABL oncogene. Interestingly, RelA interacts
with the cyclin E:CDK2 complex through the p300
adapter protein and its cooperative transcriptional ef-
fect with the CDKI inhibitor p21 poses provocative
questions as to the function of NF-B in the cell cycle
[14]. Recent evidence suggests that NF-B is involved
in G0/G1 to S-phase transition in fibroblast cell lines
and inhibits myogenic differentiation through kinetic
and transcriptional regulation of cyclin D1 [15–17].
1
These authors equally contributed to this work.
2
To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 204-0679. E-mail: kkhalili@astro.temple.edu.
0014-4827/01 $35.00 221
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
Experimental Cell Research 265, 221–233 (2001)
doi:10.1006/excr.2001.5168, available online at http://www.idealibrary.com on